Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1053/j.ackd.2020.09.003 http://scihub22266oqcxt.onion/10.1053/j.ackd.2020.09.003 33308501!7574722!33308501     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Adv+Chronic+Kidney+Dis 2020 ; 27 (5): 365-376 Nephropedia Template TP {{tp|p=33308501|t=2020. Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19 |pdf=|usr=}}{{33308501}} gab.com Text Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19 JO: Adv Chronic Kidney Dis http://www.kidney.de/pget.php?&tw=1&pmid=33308501 #FOAvip Acute kidney injury (AKI) is common among hospitalized patients with Coronavirus Infectious Disease 2019 (COVID-19), with the occurrence of AKI ranging from 0.5% to 80%. The variability in the occurrence of AKI has been attributed to the difference in geographic locations, race/ethnicity, and severity of illness. AKI among hospitalized patients is associated with increased length of stay and in-hospital deaths. Even patients with AKI who survive to hospital discharge are at risk of developing chronic kidney disease or end-stage kidney disease. An improved knowledge of the pathophysiology of AKI in COVID-19 is crucial to mitigate and manage AKI and to improve the survival of patients who developed AKI during COVID-19. The goal of this article is to provide our current understanding of the etiology and the pathophysiology of AKI in the setting of COVID-19. Twit Text FOAVip Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19 ????Adv Chronic Kidney Dis http://www.kidney.de/pget.php?&tw=1&pmid=33308501 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33308501 #FOAvip English Wikipedia <ref>{{Cite pmid|33308501}}</ref> Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19 #MMPMID33308501 Ng JH; Bijol V; Sparks MA; Sise ME; Izzedine H; Jhaveri KD Adv Chronic Kidney Dis 2020[Sep]; 27 (5): 365-376 PMID33308501show ga Acute kidney injury (AKI) is common among hospitalized patients with Coronavirus Infectious Disease 2019 (COVID-19), with the occurrence of AKI ranging from 0.5% to 80%. The variability in the occurrence of AKI has been attributed to the difference in geographic locations, race/ethnicity, and severity of illness. AKI among hospitalized patients is associated with increased length of stay and in-hospital deaths. Even patients with AKI who survive to hospital discharge are at risk of developing chronic kidney disease or end-stage kidney disease. An improved knowledge of the pathophysiology of AKI in COVID-19 is crucial to mitigate and manage AKI and to improve the survival of patients who developed AKI during COVID-19. The goal of this article is to provide our current understanding of the etiology and the pathophysiology of AKI in the setting of COVID-19. |Acute Kidney Injury/etiology/*metabolism/pathology/physiopathology[MESH] |Anti-Bacterial Agents/adverse effects[MESH] |Antiviral Agents/adverse effects[MESH] |Apolipoprotein L1/genetics[MESH] |Ascorbic Acid/adverse effects[MESH] |Azotemia/metabolism/pathology/physiopathology[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19/*metabolism/pathology/physiopathology[MESH] |Cytokines/*metabolism[MESH] |Disease Progression[MESH] |Glomerulonephritis, Membranous/metabolism/pathology/physiopathology[MESH] |Glomerulonephritis/*metabolism/pathology/physiopathology[MESH] |Hospital Mortality[MESH] |Humans[MESH] |Kidney Tubules, Proximal/injuries[MESH] |Length of Stay[MESH] |Myoglobin/metabolism[MESH] |Nephritis, Interstitial/metabolism/pathology/physiopathology[MESH] |Nephrosis, Lipoid/metabolism/pathology/physiopathology[MESH] |Renal Insufficiency, Chronic[MESH] |Rhabdomyolysis/metabolism[MESH] |SARS-CoV-2[MESH] |Severity of Illness Index[MESH] |Thrombotic Microangiopathies/*metabolism/pathology/physiopathology[MESH]Pathophysiology and Pathology of Acute Kidney Injury in Patients With (epmc).pdf DeepDyve Pubget Overpricing